Acorda Therapeutics (ACOR): Q3 EPS of $0.38 beats by $0.14. Revenue of $77.4M (-16.8% Y/Y) beats...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor
Acorda Therapeutics (ACOR): Q3 EPS of $0.38 beats by $0.14. Revenue of $77.4M (-16.8% Y/Y) beats by $2.2M. (PR)